Drug Addition | cAMP | ||
---|---|---|---|
At 0 min | At 60 min | At 60 min | At 120 min |
pmol/106cells | |||
Forskolin, 1 μM | 660 ± 54 | 581 ± 54 | |
Forskolin, 1 μM + | 324 ± 30** | ||
PD 115199, 2.5 nM | (−52%) | ||
Forskolin, 1 μM | PD 115199, 2.5 nM | 306 ± 18** | |
(−48%) | |||
Forskolin, 10 μM | 2071 ± 201 | 1319 ± 114 | |
Forskolin, 10 μM + | 1393 ± 118** | ||
PD 115199, 2.5 nM | (−33%) | ||
Forskolin, 10 μM | PD 115199, 2.5 nM | 858 ± 106* | |
(−35%) |
Data are the means ± S.E.M. of six to eight replicates. Results were compared using an ANOVA followed by the Newman-Keuls range test. The asterisks (*P < .05; ** P< .01) denote significance of PD 115199 treatment at different times on forskolin activity.